Robotically assisted cardiac surgery: minimally invasive techniques to totally endoscopic heart surgery.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or synthesis methodology
PubMed 14680342 · doi:10.1097/00005082-200311000-00010
What was done
This narrative review describes the progression of minimally invasive cardiac surgery from partial sternotomy to totally endoscopic robotic-assisted heart surgery. It outlines regulatory pathways involving mandated clinical trials and surgeon proficiency testing for the two major equipment manufacturers, and summarizes clinical applications in coronary bypass, valve surgery, and congenital repairs.
What was found
The abstract reports no numerical data, sample sizes, or quantitative outcome measures. It notes qualitatively that robotic enhancement is established for coronary artery bypass grafting and selected valve surgeries, and is expanding into congenital cardiac surgery via totally endoscopic atrial septal defect closure.
Why it matters
Provides an early overview of the shift toward totally endoscopic cardiac surgery and the regulatory requirements governing robotic surgical systems.
Limits
As a narrative review with no systematic methodology or primary human data in the abstract, it offers no comparative outcome metrics, complication rates, or sample size details.
Cited by
- context Dr. Steven Gundry has published more than 300 articles in peer-reviewed journals on using diet and supplements to eliminate heart disease, diabetes, and autoimmune conditions.